Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Sara Gibiino & Alessandro Serretti. (2012)
Paroxetine for the treatment of depression: a critical update. Expert Opinion on Pharmacotherapy 13:3, pages 421-431.
Read now
Read now
Mazen K Ali & Raymond W Lam. (2011) Comparative efficacy of escitalopram in the treatment of major depressive disorder. Neuropsychiatric Disease and Treatment 7, pages 39-49.
Read now
Read now
J.P. Boulenger, A. Hermes, A.K.T. Huusom & E. Weiller. (2010) Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine. Current Medical Research and Opinion 26:3, pages 605-614.
Read now
Read now
Cyril Höschl & Jaromír Švestka. (2008) Escitalopram for the treatment of major depression and anxiety disorders. Expert Review of Neurotherapeutics 8:4, pages 537-552.
Read now
Read now
Naomi A. Fineberg. (2007) New treatment options for OCD. International Journal of Psychiatry in Clinical Practice 11:sup2, pages 24-30.
Read now
Read now
J.-P. Boulenger, A. K. T. Huusom, I. Florea, T. Bækdal & M. Sarchiapone. (2006) A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Current Medical Research and Opinion 22:7, pages 1331-1341.
Read now
Read now
Raymond W. Lam. (2006) Challenges in the treatment of anxiety disorders: beyond guidelines. International Journal of Psychiatry in Clinical Practice 10:sup3, pages 18-24.
Read now
Read now
Articles from other publishers (17)
Nather Madjid, Veronica Lidell, Gunnar Nordvall, Maria Lindskog, Sven-Ove Ögren, Pontus Forsell & Johan Sandin. (2023) Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?. Psychopharmacology 240:8, pages 1789-1804.
Crossref
Crossref
Emiliano Tesoro-Cruz, Leticia Manuel-Apolinar, Norma Oviedo, Sandra Orozco-Suárez, Minerva Crespo Ramírez, Vilma Carolina Bekker-Méndez, M. Magdalena Aguirre-García, Sandra Angélica Rojas-Osornio, Vladimir Paredes-Cervantes & Miguel Pérez de la Mora. (2021) Increase of 5-HT levels is induced both in mouse brain and HEK-293 cells following their exposure to a non-viral tryptophan hydroxylase construct. Translational Psychiatry 11:1.
Crossref
Crossref
Lobna A. AbdelwahabOmneya O. GalalSahar S. Abd El-Rahman, Amany I. El-BrairyMahmoud M. Khattab & Aiman S. El-Khatib. (2021) Targeting the Oxytocin System to Ameliorate Early Life Depressive-Like Behaviors in Maternally-Separated Rats. Biological and Pharmaceutical Bulletin 44:10, pages 1445-1457.
Crossref
Crossref
Emiliano Tesoro-Cruz, Norma Oviedo, Leticia Manuel-Apolinar, Sandra Orozco-Suárez, Miguel Pérez de la Mora, Gloria Martínez-Pérez, Francisco Xavier Guerra-Castillo, Charmina Aguirre-Alvarado & Vilma Carolina Bekker-Méndez. (2020) Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures. Molecular Biotechnology 62:3, pages 200-209.
Crossref
Crossref
Salina Akter, Hiroyuki Sasaki, Yuko Ikeda, Hiroki Miyakawa & Shigenobu Shibata. (2018) γ-oryzanol ameliorates the acute stress induced by behavioral anxiety testing in mice. Journal of Pharmacological Sciences 138:2, pages 155-159.
Crossref
Crossref
Ravid Doron, Avital Sever, Assaf Handelsman, Roni Toledano, Motty Franko, Yafit Hirshler, Alon Shamir, Or Burstein & Moshe Rehavi. (2018) GABAA Receptor Density Is Not Altered by a Novel Herbal Anxiolytic Treatment. Journal of Molecular Neuroscience 65:1, pages 110-117.
Crossref
Crossref
Ravid Doron, Dafna Lotan, Ziv Versano, Layla Benatav, Motty Franko, Shir Armoza, Nadav Kately & Moshe Rehavi. (2014) Escitalopram or Novel Herbal Mixture Treatments during or following Exposure to Stress Reduce Anxiety-Like Behavior through Corticosterone and BDNF Modifications. PLoS ONE 9:4, pages e91455.
Crossref
Crossref
Ravid Doron, Dafna Lotan, Anat Rak-Rabl, Adi Raskin-Ramot, Karen Lavi & Moshe Rehavi. (2012) Anxiolytic effects of a novel herbal treatment in mice models of anxiety. Life Sciences 90:25-26, pages 995-1000.
Crossref
Crossref
Michael E. Thase. (2011) Combined Antidepressant Strategies Are Not More Effective Than Vigorous Escitalopram Monotherapy: Results of the CO-MED Study. Current Psychiatry Reports 13:6, pages 434-436.
Crossref
Crossref
Yuyan Jin, Bruce G. Pollock, Ellen Frank, Giovanni B. Cassano, Paola Rucci, Daniel J. Müller, James L. Kennedy, Rocco Nicola Forgione, Margaret Kirshner, Gail Kepple, Andrea Fagiolini, David J. Kupfer & Robert R. Bies. (2010) Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure. The Journal of Clinical Pharmacology 50:1, pages 62-72.
Crossref
Crossref
Leea H. Muhonen, Jouko Lönnqvist, Jari Lahti & Hannu Alho. (2009) Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence. Psychiatry Research 167:1-2, pages 115-122.
Crossref
Crossref
Leea H Muhonen, Jari Lahti, David Sinclair, Jouko Lönnqvist & Hannu Alho. (2008) Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication. Substance Abuse Treatment, Prevention, and Policy 3:1.
Crossref
Crossref
Dan Atar, Alex Malinin, Alex Pokov, Louis van Zyl, Nancy Frasure-Smith, Francois Lesperance & Victor L Serebruany. (2007) Antiplatelet Properties of Escitalopram in Patients with the Metabolic Syndrome: A Dose-Ranging In Vitro Study. Neuropsychopharmacology 32:11, pages 2369-2374.
Crossref
Crossref
Christoffer Bundgaard, Frank Larsen, Martin Jørgensen & Arne Mørk. (2007) Pharmacokinetic/Pharmacodynamic Feedback Modelling of the Functional Corticosterone Response in Rats after Acute Treatment with Escitalopram. Basic & Clinical Pharmacology & Toxicology 100:3, pages 182-189.
Crossref
Crossref
Christoffer Bundgaard, Martin Jørgensen & Arne Mørk. (2007) An integrated microdialysis rat model for multiple pharmacokinetic/pharmacodynamic investigations of serotonergic agents. Journal of Pharmacological and Toxicological Methods 55:2, pages 214-223.
Crossref
Crossref
Christoffer Bundgaard, Frank Larsen, Martin Jørgensen & Johan Gabrielsson. (2006) Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: Application to escitalopram-induced effects on brain serotonin levels. European Journal of Pharmaceutical Sciences 29:5, pages 394-404.
Crossref
Crossref
Sohita Dhillon, Lesley J Scott & Greg L Plosker. (2006) Escitalopram. CNS Drugs 20:9, pages 763-790.
Crossref
Crossref